The goal of this clinical trial is to learn about the effectiveness of extracorporeal shockwave(ESWT) combined with platelet-rich plasma(PRP) to treat chronic insertional tendinopathy. The main questions it aims to answer are: Does ESWT combined with PRP treatment reduce the symptom and improve functional score after treatment? What medical complication do participants have when receive the treatment? Researchers will compare ESWT combined with PRP to ESWT treatment alone to see if ESWT combined with PRP works to treat chronic insertional tendinopathy. Participants will: * Receive ESWT once a week for 4 weeks then receive PRP injection at a week later or ESWT once a week for 4 weeks * Visit the clinic at 6 weeks, 3 months, 6 months and 1 year after treatment for checkups and record functional score
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
94
Receive ESWT once a week for 4 weeks
Receive PRP injection at week 5
Ramathibodi hospital
Ratchathewi, Bangkok, Thailand
VAS
Visual Analogue Scale
Time frame: 6 week, 3 months, 6 months and 1 year after treatment
VAS-FA
Visual analogue scale foot and ankle
Time frame: 6 week, 3 months, 6 months and 1 year after treatment
FFI
Foot functional index
Time frame: 6 week, 3 months, 6 months and 1 year after treatment
FAAM
Foot and Ankle Ability Measure
Time frame: 6 week, 3 months, 6 months and 1 year after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.